Assessment of Sexual Healthcare in Maryland Safety Net Providers Sites: Creation of the Sexual Health Integration Network Katherine Jochim, RN Karen Silver, MPP Office of Population Health Improvement Maryland Department of Health and Mental Hygiene May 2013 Overview Introduction: The Frontier of Sexual Health in Maryland Methods: Creation of SHINE Development of Assessment Survey Findings Limitations and Challenges Lessons Learned Policy and Practice Implications Sexual Health in Maryland The Burden of HIV in Maryland Ranked 3rd in States/Territories in estimated HIV diagnoses in 2011 Ranked 4th in States/Territories in estimated number of persons living with diagnosed HIV Total lifetime treatment cost for all new HIV diagnoses is $514 million (in 2009). Trends in Living HIV Cases MD HIV/AIDS Epidemiological Profile, Bureau of Infectious Diseases, DHMH. 2011 Continuum of HIV Care MD HIV/AIDS Epidemiological Profile, Bureau of Infectious Diseases, DHMH. 2011 The Burden of STIs in Maryland MD Ranking in US States/Territori es 2011 MD Rate 2011 US Rate Gonorrhea 16 111.9 104.2 Chlamydia 15 670.9 648.9 Syphilis 3 7.8 4.5 Congenital Syphilis 2 31.1** 8.5 *per 100,000 people **per 100,000 live births CDC Sexually Transmitted Diseases Surveillance Data, 2011 The Affordable Care Act • Increased Medicaid eligibility to individuals at or below 133% the federal poverty level • Provides insurance exchanges for those at or below the 400% federal poverty level (who are not eligible for Medicaid or Medicare) • Children <26 years can remain on parents’ insurance plan • 30 million people are expected to have new insurance coverage • This will affect sexual healthcare in unanticipated ways. The Creation of SHINE (Sexual Health Integration Network) Initial Goals: Holistic sexual health Do not silo HIV, STIs and viral hepatitis Create standard protocols for all federally funded safety net providers. Federally-qualified health centers (FQHCs) and look-alike Local health departments (LHDs) Community Health Centers (CHCs) School-based Health Centers (SBHCs) Hospital clinics Title X Clinics Use other states, such as Oregon, as a model for integration and protocols. Identification of Stakeholders DHMH Center for HIV Surveillance Office of Family Planning Office of Primary Care Access Other members from the Infectious Diseases Bureau and the Office of Population Health Baltimore City Health Department As well as other LHDs around the state FQHC Representatives Johns Hopkins University Revised Goals Perform assessment of current sexual health practices in the state of Maryland. Holistic sexual health Do not silo HIV, STIs and viral hepatitis Develop standard protocols for all federally funded safety net providers. Development of Assessment Survey Clinical Guidelines Recommendations: Recommending Body: Treatment of HIV/STIs ACOG, ACP, USPSTF, CDC Disease Screening USPSTF, CDC, HRSA, HEDIS Counseling ACOG, CDC, USPSTF American College for Obstetricians and Gynecologists (ACOG) American College of Physicians (ACP) United States Preventive Services Task Force (USPSTF) Centers for Disease Control and Prevention (CDC) Health Resources and Services Administration (HRSA) Health Effectiveness Data and Information Set (HEDIS) The Holistic Assessment HIV/STI treatment HIV/STI screening HPV and Hepatitis Vaccinations Condom availability Social Services Partner Services Mental Health Substance Abuse Behavioral Counseling Referral Process Pilot Survey www.education.randmcnally.com Pilot County Characteristics Prince George’s County Dorchester County Allegany County Elevated rates; higher pop. density Average rates of STI/HIV Lower rates; rural area Geographic location Middle-south Eastern Shore Western HIV/AIDS prevalence 799 403 118 Chlamydia rate 698 506 234 Syphilis rate 11 6 3 Gonorrhea rate 184 235 41 Representative characteristic *HIV/AIDS information based on 2011 statistics. Data from the Maryland HIV/AIDS Epidemiological Profile, Third Quarter, 2012 by the Center of HIV Surveillance, Epidemiology and Evaluation, DHMH. **STI information based on 2011 statistics. Data from the Center for Sexually Transmitted Infection Prevention, DHMH. Pilot Survey Implementation Survey built using Survey Monkey BETA version can be taken at: https://www.surveymonkey.com/s/SHINEAssetMappingSurveyTEST Notified providers of impending survey via telephone on April 8, 2013 Emailed survey to providers April 8, 2013 Surveys were due April 22, 2013 Findings Results Pending 23/28 surveys have been returned Current Result Summary: All providers offer HIV testing Following CDC guidelines All providers offer STI testing Treat patients in house with oral or injectable treatment Primarily follow CDC guidelines Majority provide hepatitis and HPV vaccines Very few offer partner services Demographics Please select the county (or counties) that your facility primarily serves. 70.0% 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% Please specify type of facility. (Check all that apply) Other Hospitalbased Clinic Hospital Emergen cy Departme nt Communi ty Health Center Schoolbased Health Center Local Health Departme nt FQHC look-alike Federally Qualified Health Center (FQHC) 60.0% 50.0% 40.0% 30.0% 20.0% 10.0% 0.0% 40.00 40.0% 35.00 30.0% 30.00 20.0% 25.00 10.0% 20.00 0.0% 15.00 10.00 5.00 .00 Other (please specify) 50.0% When symptoms are present 45.00 When diagnosed with an STI 60.0% Prenatal visit 50.00 When patient identified risk OR requested by patient Please quantify (by percentage) the patient population by payer type in the past 12 months. Routine - (every patient entering the provider's care is offered an HIV test) Other N/A % Unknown % Self-pay % Uninsured % Private % Public Payer Type and HIV Testing Under what circumstances do you provide HIV testing? 70.0% Linkage to Care Steps Taken to Ensure Patients Remain Linked to HIV Treatment 50% 40% 30% 20% 10% 0% Referral In House Treatment Follow Up in Schools Social Services 0 Social Support Services Intensive behavioral counseling (counseling to… Mental Health and/or Substance Abuse Support Partner Services (patient is interviewed to identify… HIV Specialty Care HIV Treatment Treatment Services If the patient tests positive for HIV, does your facility provide the following services? 35 30 25 In House 20 15 Willing to receive referrals for this service 10 Refer Out 5 N/A STI Vaccines STI vaccinations: 30 25 We provide this service on-site. 20 We accept patients referred to us for this service. 15 We do not provide this service. 10 We would like to refer out this service. 5 0 Hepatitis A Vaccine Hepatitis B Vaccine HPV Vaccine Social Support Services Intensive behavioral counseling** for adults at increased risk for STIs Intensive behavioral counseling** to sexually active adolescents Mental Health and/or Substance Abuse Support Partner services* for gonorrhea Partner services* for chlamydia Partner services* for syphilis STI Treatment Services If the patient tests positive for an STI 30 25 We provide this service on-site. 20 We accept patients referred to us for this service. 15 We refer out for this service. 10 5 We would like to refer out for this service. 0 Limitations and Challenges Fluctuating timeline Contact information for providers Poor response rate Lessons Learned • • • • • Be flexible. Be patient. Utilize your resources. Be positive. The DHMH is not glamorous. • But, it is dedicated, hard-working, and thorough. Google Image, 2013 Policy and Practice Implications Official implications are pending. My recommendations: Invite a representative from each LHD to SHINE for a voice in the network. Follow CDC guidelines only when implementing standard protocol. Provide increased incentives for clinics to report HIV/STIs and fines if they do not. Before receiving federal funds, clinics must identify from where they receive referrals or to whom they refer, ensuring that effective linkages exist between providers. Increase funding for partner services and disease intervention specialists. References Brown, A. G., Governor, L., & Colmers, J. M. (2011). Health Care Reform Coordinating Council (pp. 1–30). Baltimore. Retrieved from http://www.healthreform.maryland.gov/wp-content/uploads/2012/03/FINALREPORT.pdf CDC. (2010). HIV/AIDS - Statistics and Surveillance - Reports - HIV Surveillance Report 2010. Centers for Disease Control and Prevention. Retrieved February 27, 2013, from http://www.cdc.gov/hiv/surveillance/resources/reports/2010report/index.htm CDC. (2011a). 2010 STD Treatment Guidelines. Centers for Disease Control and Prevention. Retrieved February 27, 2013, from http://www.cdc.gov/std/treatment/2010/toc.htm CDC. (2011b). Guidelines | HIV/AIDS. Centers for Disease Control and Prevention: Division of HIV/AIDS Prevention Guidelines. Retrieved February 27, 2013, from http://www.cdc.gov/hiV/resources/guidelines/ CDC. (2011c). STD Surveillance, 2011. Centers for Disease Control and Prevention. Retrieved February 27, 2013, from http://www.cdc.gov/std/stats11/toc.htm CDC. (2013). Sexual Health. Centers for Disease Control and Prevention. Retrieved March 28, 2013, from http://www.cdc.gov/sexualhealth/#who CDC (Centers for Disease Control and Prevention). (2012a). Chlamydia. 2011 Sexually Transmitted Disease Surveillance. Retrieved April 17, 2013, from http://www.cdc.gov/std/stats11/chlamydia.htm CDC (Centers for Disease Control and Prevention). (2012b). Syphilis. 2011 Sexually Transmitted Disease Surveillance. CDC, & HRSA. (2012). Advisory Committee on HIV , Viral Hepatitis and STD Prevention and Treatment (pp. 1–54). Atlanta. Retrieved from http://www.cdc.gov/maso/facm/pdfs/CHACHSPT/20120508_CHAC.pdf Chen, M., Rhodes, P., Hall, H. I., Kilmarx, P. H., Branson, B. M., & Valeroy, L. A. (2012). Prevalence of Undiagnosed HIV Infection Among Persons Aged ≥13 Years — National HIV Surveillance System, United States, 2005–2008. MMWR. Morbidity and mortality weekly report, 61 Suppl, 57–64. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22695456 Chow, J. M. (2012). Measuring the uptake and impact of Chlamydia screening programs--easier said than done. Sexually transmitted diseases, 39(2), 89–91. doi:10.1097/OLQ.0b013e318245f95c Cohen, S. M., Van Handel, M. M., Branson, B. M., Blair, J. M., Hall, H. I., Hu, X., Koenig, L. J., et al. (2011). Vital signs: HIV prevention through care and treatment--United States. MMWR. Morbidity and mortality weekly report, 60(47), 1618–23. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22129997 DHMH. (2012a). SHIP HOME - Home. Maryland Department of Health and Mental Hygiene. Retrieved March 27, 2013, from http://dhmh.maryland.gov/ship2/SitePages/Home.aspx DHMH. (2012b). Strengthening Public Health Infrastrutures for Improved Public Health Outcomes - Continuation. Baltimore, MD. Fenton, K. a. (2010). Time for Change: Rethinking and Reframing Sexual Health in the United States. The Journal of Sexual Medicine, 7(suppl 5), 250–252. doi:10.1111/j.1743-6109.2010.02057.x Frerich, E. a, Garcia, C. M., Long, S. K., Lechner, K. E., Lust, K., & Eisenberg, M. E. (2012). Health care reform and young adults’ access to sexual health care: an exploration of potential confidentiality implications of the affordable care act. American journal of public health, 102(10), 1818–21. doi:10.2105/AJPH.2012.300857 Golden, M. R., Hopkins, S. G., Morris, M., Holmes, K. K., & Handsfield, H. H. (2003). Support among persons infected with HIV for routine health department contact for HIV partner notification. Journal of acquired immune deficiency syndromes (1999), 32(2), 196–202. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12571530 Gray, C. (2012). HIV and Viral Hepatitis - Maryland (pp. 1–12). Baltimore, MD. HEDIS. (2013). List of HEDIS 2013 Measures. Healthcare Effectiveness Data and Information Set. Retrieved from http://www.ncqa.org/Portals/0/HEDISQM/HEDIS2013/List_of_HEDIS_2013_Measures_7.2.12.pdf HRSA. (2006). Safety Net Provider Information for Part D Sponsors. Retrieved April 18, 2013, from http://www.hrsa.gov/medicare/forpartdsponsors.htm HRSA. (2011). Clinical Care Guidelines/Protocols. Health Resources and Services Administration. Retrieved February 28, 2013, from http://hab.hrsa.gov/deliverhivaidscare/clinicalguidelines.html HRSA. (2013). Health Center Program Terminology Tip Sheet. Retrieved from http://bphc.hrsa.gov/technicalassistance/healthcenterterms.pdf Ivankovich, M. B., Fenton, K. a, & Douglas, J. M. (2013). Considerations for national public health leadership in advancing sexual health. Public health reports (Washington, D.C. : 1974), 128 Suppl , 102–10. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23450891 Ivankovich, M. B., Leichleiter, J. S., & Douglas, J. M. (2013). Measurement of Sexual Health in the U . S .: An Inventory of Nationally Representative Surveys and Surveillance Systems (Vol. 128, pp. 62–72). Retrieved from http://webcache.googleusercontent.com/search?q=cache:tYmCwsFAf8gJ:www.publichealthreports.org/issueopen.cfm%3Farti cleID%3D2940+&cd=1&hl=en&ct=clnk&gl=us&client=firefox-a Lanier, Y., & Sutton, M. Y. (2013). Reframing the context of preventive health care services and prevention of HIV and other sexually transmitted infections for young men: new opportunities to reduce racial/ethnic sexual health disparities. American journal of public health, 103(2), 262–9. doi:10.2105/AJPH.2012.300921 Meyers, D., Wolff, T., Gregory, K., Marion, L., Moyer, V., Nelson, H., Petitti, D., et al. (2008). USPSTF recommendations for STI screening. American family physician, 77(6), 819–24. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23432900 Owusu-Edusei, K., Chesson, H. W., Gift, T. L., Tao, G., Mahajan, R., Ocfemia, M. C. B., & Kent, C. K. (2013). The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sexually transmitted diseases, 40(3), 197–201. doi:10.1097/OLQ.0b013e318285c6d2 Saleeby, E., & Brindis, C. (2011). Women, reproductive health, and health reform. JAMA: the journal of the American Medical …, 306(11), 1256–1257. Retrieved from http://jama.ama-assn.org/content/306/11/1256.short Sharpe, T. T., Harrison, K. M., & Dean, H. D. (2010). Summary of CDC consultation to address social determinants of health for prevention of disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis. December 9-10, 2008. Public health reports (Washington, D.C. : 1974), 125 Suppl , 11–5. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2882970&tool=pmcentrez&rendertype=abstract SHINE (Sexual Health Integration Network). (2012). Meeting Minutes for SHINE (p. 4). Baltimore, MD. Smith, B. (NCSD). (2013). Impact of Affordable Care Act on STI Prevention and Control Programs. Baltimore, MD. Sonfield, A., & Pollack, H. A. (2013). The Policy and Politics of Reproductive Health The Affordable Care Act and Reproductive Health : Potential Gains and Serious Challenges. Journal of Health Politics, Policy and Law, 38(2), 373–391. doi:10.1215/03616878Stefanacci, R. G. (2013). Impact of health care reform on reproductive service providers. The Journal of reproductive medicine, 58(1-2), 3–6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23447911 Taylor, M. M., Mickey, T., Winscott, M., James, H., Kenney, K., & England, B. (2010). Improving partner services by embedding disease intervention specialists in HIV-clinics. Sexually transmitted diseases, 37(12), 767–70. doi:10.1097/OLQ.0b013e3181e65e8b USPSTF. (2005). Screening for HIV. United States Preventive Services Task Force. Retrieved February 27, 2013, from http://www.uspreventiveservicestaskforce.org/uspstf/uspshivi.htm WHO. (2013). Gender and human rights. World Health Organization: Sexual health document series. World Health Organization. Retrieved February 27, 2013, from http://www.who.int/reproductivehealth/topics/gender_rights/sexual_health/en/ Questions?
© Copyright 2026 Paperzz